Company news

Rockwell Medical, Inc. news in 2021

Rockwell Medical, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Rockwell Medical Receives Important Feedback from FDA on its IND Application for Phase 2 Trial of Ferric Pyrophosphate Citrate in Home Infusion

December 13, 2021

Rockwell Medical, Inc. Provides Third Quarter 2021 Financial and Operational Update

November 14, 2021

Rockwell Medical Submits Investigational New Drug Application with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion

November 10, 2021

Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

August 18, 2021

Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational Update

August 15, 2021

Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion

June 27, 2021

Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates

June 10, 2021

Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic® in Turkey

June 7, 2021

Rockwell Medical, Inc. Provides First Quarter 2021 Financial and Operational Update

May 16, 2021

Rockwell Medical Announces Marketing Approval of Triferic® AVNU™ in Canada

April 26, 2021

Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational Update

March 30, 2021

Rockwell Medical, Inc. to Report Fourth Quarter and Full Year 2020 Financial and Operating Results on March 31, 2021

March 17, 2021

Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis

February 8, 2021

Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.

January 31, 2021

Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China

January 12, 2021

Calls in 2021